Related Experiment Video

Updated: Oct 8, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Changes in the pathogenesis and prevention of chronic lung disease of prematurity

E Bancalari1

  • 1Department of Pediatrics, University of Miami School of Medicine, FL 33101, USA.

American Journal of Perinatology
|April 26, 2001
PubMed

Insights

Newer forms of chronic lung disease (CLD) in premature infants are linked to infections and patent ductus arteriosus (PDA). Early intervention for these factors is crucial for preventing lung damage in high-risk newborns.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Perinatal Medicine

Background:

  • Increasing survival rates of extremely premature infants have led to a rise in chronic lung disease (CLD).
  • This newer form of CLD is less severe than classic bronchopulmonary dysplasia (BPD) and may involve factors beyond oxygen toxicity and barotrauma.
  • The pathogenesis of this milder CLD is multifactorial, involving injury to the immature lung.

Purpose of the Study:

  • To identify key factors contributing to the development of chronic lung disease in extremely premature infants.
  • To propose preventative strategies targeting the identified etiological agents of CLD.
  • To highlight the role of infections and patent ductus arteriosus (PDA) in the pathogenesis of milder CLD.

Main Methods:

  • Review of clinical and epidemiological data related to CLD in premature infants.
  • Analysis of factors contributing to lung injury in the neonatal intensive care unit (NICU) setting.
  • Correlation of prenatal and nosocomial infections and PDA with CLD development.

Main Results:

  • Clinical and epidemiological evidence strongly implicates infections (prenatal and nosocomial) as a major factor in CLD development.
  • The presence of a patent ductus arteriosus (PDA) is also identified as a significant contributor to CLD in this population.
  • These factors play a major role in the pathogenesis of the milder form of CLD observed in survivors of extreme prematurity.

Conclusions:

  • Prevention of CLD in extremely low birth weight infants requires addressing multiple contributing factors.
  • Aggressive prevention and treatment of prenatal and neonatal infections are essential.
  • Early closure of the patent ductus arteriosus (PDA) should be a key component of CLD prevention strategies.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Introduction to Language of Pathophysiology ll01:17

Introduction to Language of Pathophysiology ll

This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: